Anticoagulant News and Research

RSS
New rule from CMS for improving stroke patient care in hospitals

New rule from CMS for improving stroke patient care in hospitals

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Regado Biosciences to commence Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system

Regado Biosciences to commence Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system

Thick blood to cause or prevent strokes and heart attacks proved by scientists

Thick blood to cause or prevent strokes and heart attacks proved by scientists

Aryx Therapeutics reports Q2 2009 financials

Aryx Therapeutics reports Q2 2009 financials

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Voice response system useful for monitoring anticoagulant patients

Voice response system useful for monitoring anticoagulant patients

New method to estimate bleeding risk in heart attack patients

New method to estimate bleeding risk in heart attack patients

Complementary and alternative medicines can be safe, effective for kids

Complementary and alternative medicines can be safe, effective for kids

Discovery of link between atrial fibrillation and increased risk of death in diabetic patients

Discovery of link between atrial fibrillation and increased risk of death in diabetic patients

Kidney disease increases risk of stroke in patients with atrial fibrillation

Kidney disease increases risk of stroke in patients with atrial fibrillation

Kidney disease affects response to anticoagulant drug warfarin

Kidney disease affects response to anticoagulant drug warfarin

Study reveals high level of adverse drug reactions in hospitals

Study reveals high level of adverse drug reactions in hospitals

FDA approves orphan drug ATryn anticoagulant

FDA approves orphan drug ATryn anticoagulant

Entomologists look for Lyme disease answers in tick saliva

Entomologists look for Lyme disease answers in tick saliva

New approaches to prevent blood clots

New approaches to prevent blood clots

Daiichi Sankyo starts trial of investigational factor Xa inhibitor for atrial fibrillation

Daiichi Sankyo starts trial of investigational factor Xa inhibitor for atrial fibrillation

Idiopathic pulmonary fibrosis linked to heart attacks

Idiopathic pulmonary fibrosis linked to heart attacks

Scientists create synthetic Heparin in more varieties

Scientists create synthetic Heparin in more varieties

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)